• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

30例类癌综合征患者动脉去血管化及细胞毒性药物的应用

Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.

作者信息

Melia W M, Nunnerley H B, Johnson P J, Williams R

出版信息

Br J Cancer. 1982 Sep;46(3):331-9. doi: 10.1038/bjc.1982.208.

DOI:10.1038/bjc.1982.208
PMID:6181801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2011132/
Abstract

Thirty patients with symptoms of the carcinoid syndrome and other symptoms not controlled by pharmacological agents were analysed with respect to the value of various treatment measures used. Tumour devascularization was carried out in 11 patients, either by surgical ligation of the main hepatic artery (6) or by percutaneous arterial embolization (5). The latter was shown to be the safer technique, both with respect to initial morbidity/mortality and other side effects. Control of flushing and diarrhoea was achieved in 80% and the technique was also repeated on one occasion with success when symptoms recurred. The use of cytotoxic drugs alone, including 5-fluorouracil, cyclophosphamide and Adriamycin produced symptomatic relief in only 4 of the 22 patients treated. They should only be considered if devascularization by arterial embolization proves impossible or cannot be repeated when symptoms recur.

摘要

对30例患有类癌综合征症状且其他症状无法通过药物控制的患者,分析了所采用的各种治疗措施的价值。11例患者进行了肿瘤去血管化治疗,其中6例通过手术结扎肝总动脉,5例通过经皮动脉栓塞。结果表明,就初始发病率/死亡率和其他副作用而言,后者是更安全的技术。80%的患者潮红和腹泻症状得到控制,当症状复发时,该技术还成功重复使用了一次。单独使用细胞毒性药物,包括5-氟尿嘧啶、环磷酰胺和阿霉素,在接受治疗的22例患者中只有4例症状得到缓解。只有当动脉栓塞去血管化证明不可能或症状复发时无法重复进行时,才应考虑使用细胞毒性药物。

相似文献

1
Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.30例类癌综合征患者动脉去血管化及细胞毒性药物的应用
Br J Cancer. 1982 Sep;46(3):331-9. doi: 10.1038/bjc.1982.208.
2
Hepatic arterial embolisation in patients with metastatic carcinoid tumours.转移性类癌肿瘤患者的肝动脉栓塞术
Clin Radiol. 1985 Nov;36(6):597-602. doi: 10.1016/s0009-9260(85)80241-5.
3
Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.肝动脉栓塞术——治疗恶性类癌综合征的新方法。
Dtsch Z Verdau Stoffwechselkr. 1986;46(2):130-6.
4
Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
J Clin Oncol. 1983 Nov;1(11):727-40. doi: 10.1200/JCO.1983.1.11.727.
5
Embolization of the liver in the management of metastatic carcinoid tumors.肝动脉栓塞术在转移性类癌肿瘤治疗中的应用
J Surg Oncol. 1984 Nov;27(3):152-8. doi: 10.1002/jso.2930270305.
6
Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.类癌肿瘤肝转移的肝动脉栓塞治疗:使用氰基丙烯酸酯和碘化油混合物的价值
AJR Am J Roentgenol. 1995 Aug;165(2):323-7. doi: 10.2214/ajr.165.2.7542430.
7
Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.α-干扰素2b,无论是否先行肝动脉栓塞:中肠类癌患者的临床反应与生存情况。挪威类癌研究。
Scand J Gastroenterol. 1995 Aug;30(8):789-96. doi: 10.3109/00365529509096329.
8
Hepatic dearterialization in the treatment of carcinoid syndrome.肝动脉去血管化治疗类癌综合征
Acta Chir Scand. 1987 Sep;153(9):523-9.
9
The management of patients with advanced carcinoid tumors and islet cell carcinomas.
Ann Intern Med. 1994 Feb 15;120(4):302-9. doi: 10.7326/0003-4819-120-4-199402150-00008.
10
Hepatic artery ligation in treatment of carcinoid syndrome.肝动脉结扎术治疗类癌综合征。
Can Med Assoc J. 1975 Feb 8;112(3):325-7.

引用本文的文献

1
Role of hepatic arterial embolisation in the carcinoid syndrome.肝动脉栓塞在类癌综合征中的作用。
Br Med J (Clin Res Ed). 1983 Oct 1;287(6397):932-5. doi: 10.1136/bmj.287.6397.932.
2
Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas.肠道和胰腺转移性内分泌肿瘤的肝脏移植
Surg Gynecol Obstet. 1989 Feb;168(2):107-11.
3
Hepatic artery embolization in the treatment of intractable hypoglycaemia.肝动脉栓塞术治疗顽固性低血糖症
J R Soc Med. 1990 Sep;83(9):592-3. doi: 10.1177/014107689008300920.
4
[2 year interferon therapy of metastatic carcinoid tumor].[转移性类癌瘤的两年干扰素治疗]
Klin Wochenschr. 1990 Feb 15;68(4):241-6. doi: 10.1007/BF01662725.
5
Advances in neoplastic disease of the liver and biliary tract.肝脏和胆道肿瘤性疾病的进展
Gut. 1991 Sep;Suppl(Suppl):S104-10. doi: 10.1136/gut.32.suppl.s104.

本文引用的文献

1
The effect of a serotonin antagonist (UML 491) in carcinoid disease.一种血清素拮抗剂(UML 491)对类癌病的作用。
Lancet. 1961 Nov 25;2(7213):1172-4. doi: 10.1016/s0140-6736(61)90846-7.
2
Tamoxifen in carcinoid syndrome.他莫昔芬治疗类癌综合征
N Engl J Med. 1981 Jul 2;305(1):52. doi: 10.1056/NEJM198107023050115.
3
Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome.对氯苯丙氨酸对类癌综合征患者血清素合成的抑制作用。
N Engl J Med. 1967 Nov 23;277(21):1103-8. doi: 10.1056/NEJM196711232772101.
4
Massive hepatic resection for the carcinoid syndrome.
Gut. 1969 Aug;10(8):617-22. doi: 10.1136/gut.10.8.617.
5
Treatment of the carcinoid syndrome by local removal of hepatic metastases.通过局部切除肝转移灶治疗类癌综合征。
Proc R Soc Med. 1972 May;65(5):444-5. doi: 10.1177/003591577206500505.
6
The malignant carcinoid syndrome.恶性类癌综合征。
Surg Gynecol Obstet. 1973 Oct;137(4):637-44.
7
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998).链脲佐菌素(NSC-85998)的临床抗肿瘤活性与毒性
Cancer. 1974 Oct;34(4):993-1000. doi: 10.1002/1097-0142(197410)34:4<993::aid-cncr2820340404>3.0.co;2-t.
8
Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs.
Lancet. 1970 Jul 25;2(7665):172-5. doi: 10.1016/s0140-6736(70)92533-x.
9
Response of metastatic malignant carcinoid tumor to adriamycin (NSC-123127).转移性恶性类癌肿瘤对阿霉素(NSC-123127)的反应。
Cancer Treat Rep. 1976 Mar;60(3):273-6.
10
Surgical approaches and drug treatment in the carcinoid syndrome.类癌综合征的手术治疗方法与药物治疗
Br Med J. 1978 Jul 22;2(6132):281. doi: 10.1136/bmj.2.6132.281-d.